A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Clinical trial NCT02493868 · COMPLETED
Trial details
- NCT number
- NCT02493868
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-02-15
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.